Diseases

Inaugural Nipah virus Conference convenes leading experts to strengthen global collaboration, improve efforts to combat deadly virus.

Scientists in Korea find a protein that mediates the interaction between the cellular systems involved in rapid responses against foreign genes in plants

Umetaro Suzuki (7 April 1874 – 20 September 1943) was a Japanese scientist best remembered for his research on beriberi, a disease caused by vitamin B1 deficiency, characterized by limb stiffness, paralysis and pain.

Salimuzzaman Siddiqui (19 October 1897 – 14 April 1994) was an artist and chemist from Pakistan whose research focused on natural products from plants.

Foremost society of kidney specialists highlights Singapore-led global study to better understand diabetes complications and reduce their prevalence.

Development of novel agonist antibodies to treat cancer by collaboration between academia and industry

Large-scale study to identify human adenovirus genotypes in Singapore leads to discovery of four new adenovirus strains and increase in strains linked to severe diseases. Researchers suggest use of antiviral therapies and adenovirus vaccines, and routine monitoring of adenovirus strains.

A recent research led by a scientist at City University of Hong Kong (CityU) has discovered an easily transmitted DNA piece that can make a new type of hyper-resistant and deadly superbug become hyper-virulent quickly, posing an unprecedented threat to human health.

When a fly eats sugar, a single brain cell sends simultaneous messages to stimulate one hormone and inhibit another to control glucose levels in the body. Further research into this control system with remarkable precision could shed light on the neural mechanisms of diabetes and obesity in humans.

A research team from the School of Chinese Medicine at Hong Kong Baptist University (HKBU) has successfully developed a novel aptamer, i.e. a single-stranded piece of DNA, for the treatment of osteogenesis imperfecta (OI) with the aid of artificial intelligence (AI) technology. It is the first time a drug in Hong Kong has been granted orphan drug designation by the US Food and Drug Administration (FDA).

A compound effective in killing chemotherapy-resistant glioblastoma-initiating cells (GICs) has been identified, raising hopes of producing drugs capable of eradicating refractory tumors with low toxicity.

Faulty signalling pathway causes the heart to develop unnaturally while in the embryo stage, according to Duke-NUS Medical School researchers.

X-rays could be tuned to deliver a more effective punch that destroys cancer cells and not harm the body.

Researchers from Duke-NUS Medical School, in collaboration with the Agency for Science, Technology and Research’s Bioinformatics Institute, and the University of Texas Medical Branch, USA, have discovered that the dengue virus changes its shape through mutations in Envelope protein to evade vaccines and therapeutics. The study also gives insights on the types of treatment strategies to use at different stages of infection. This could give rise to new approaches in vaccine development and treatment for dengue disease.

Differential changes in brain functional network connectivity in people with mild cognitive impairment may aid early tracking of Alzheimer’s disease and cerebrovascular disease.

The formation of excess fibrous tissue in the heart, which underlies several heart diseases, could be prevented by inhibiting specific proteins that bind to RNA while its code is being translated.

Successfully identified the existence of two types of 'gastric isthmus stem cells' with different roles and characteristics using a multi-color identification technology. Expects to clarify and treat causes of gastric diseases such as cancer.

New study reveals enzyme plays key role in potentially fatal dengue haemorrhagic fever and shock; suggests clinically approved tryptase inhibitor could be key in future targeted treatment.

UK Research and Innovation and its partners are funding 13 research programs, building collaborations across 10 countries, including Japan, China, Singapore and India.

Scientists have succeeded in reducing levels of the bovine leukemia virus (BLV) in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor. The finding could be utilized to control other diseases in cattle, and perhaps in humans someday.

New insight into a protein’s role in regulating tight DNA packing could have implications for combating tumor cell resistance to anti-cancer treatments.

A delegation from Hong Kong Baptist University (HKBU) (HKBU) won a Gold Medal with the Congratulations of Jury, a Gold Medal and a Silver Medal at the 47th International Exhibition of Inventions of Geneva held in Switzerland from 10 to 14 April 2019.

A new model may help clinicians predict the possibility of death from severe dengue infection.

Researchers at Universiti Teknologi MARA reported in the journal Medicine a rare case of hepatocellular carcinoma cells migrating from the liver and settling in the jawbone and shoulder blade of a 61-year-old man.

A new method to diagnose cancer cells inside lymph nodes could allow doctors to treat cancers before they spread around the body.

An annual influenza season forecasting challenge issued by the US Centers for Disease Control provides unique insight into epidemic forecasting, according to a study published in the journal Scientific Reports.

Secure your place today with 20% code ARN20 off the standard rate and join the discussion.

Molecular analysis reveals that long-tailed macaques from Malaysian Borneo host a previously unidentified species of Plasmodium malaria parasite.

Researchers from The Hong Kong University of Science and Technology (HKUST) (HKUST) credited with important translational science and early discovery work Significant opportunity to replicate collaborative model to develop pipeline of extracellular tRNA synthetase therapeutics

A research team consisting of scientists from The Hong Kong University of Science and Technology (HKUST) (HKUST) and Beijing Tiantan Hospital have uncovered the mutational mechanism of how a rare and deadly brain cancer –secondary glioblastoma (sGBM) – progresses from its less lethal type.